Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the

Meredith E Hasenbein1, John E Warner, Kathleen G Lambert

  • 1Department of Laboratory Medicine, Children's Hospital Boston and Harvard Medical School, Massachusetts 02115, USA.

Insights

Streptococcus pyogenes resistance to erythromycin and clindamycin is a growing concern. Multiple resistance genes, including erm(A), erm(B), and mef(A), contribute to macrolide and lincosamide antibiotic resistance in S. pyogenes strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Macrolide and lincosamide antibiotics are alternatives for penicillin-allergic patients with Streptococcus pyogenes pharyngitis.
  • Erythromycin resistance in S. pyogenes can be high, up to 48% in some US populations.
  • Resistance mechanisms involve various genes, including erm(A), erm(B), and mef(A).

Purpose of the Study:

  • To investigate the prevalence and mechanisms of erythromycin and clindamycin resistance in S. pyogenes.
  • To characterize the genetic basis of antibiotic resistance in clinical isolates.

Main Methods:

  • Analysis of 196 S. pyogenes isolates from throat cultures.
  • Phenotypic testing for erythromycin and clindamycin resistance (constitutive and inducible).
  • Molecular methods including PCR for resistance genes (erm(A), erm(B), mef(A)), pulsed-field gel electrophoresis, and emm typing.

Main Results:

  • 15.3% (15/196) of S. pyogenes isolates were resistant to erythromycin.
  • Erythromycin-resistant isolates harbored erm(B) (3 isolates, constitutive clindamycin resistance), erm(A) (5 isolates, inducible clindamycin resistance), or mef(A) (7 isolates, clindamycin susceptible).
  • Pulsed-field gel electrophoresis and emm typing indicated the presence of multiple S. pyogenes strains exhibiting resistance.

Conclusions:

  • Multiple genetic mechanisms contribute to macrolide and lincosamide resistance in S. pyogenes.
  • The study highlights the presence of diverse resistance patterns in clinical isolates.
  • Understanding these resistance mechanisms is crucial for effective treatment of S. pyogenes infections.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...